Related literature
For potential applications of benzimidazoles in medicine, see: Narasimhan et al. (2012) ; Alper et al. (2003) ; Sharma et al. (2011) . For coordination compounds of benzimidazole derivatives, see: Tellez et al. (2008) . For the crystal structure of 3-[1-(3-hydroxybenzyl)-1H-benzimidazol-2-yl]phenol, see: Eltayeb et al. (2009) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Cg1, Cg2 and Cg3 are the centroids of the C4-C9, C11-C16 and C17-C22 rings, respectively. Benzimidazole and its derivatives are of significant importance in medicinal chemistry. In these species, the presence of the benzimidazole heterocycle provides a vast variety of potential biological and clinical applications (Narasimhan et al., 2012) . Benzimidazole derivatives with potential biological activities have been widely studied for the treatment of different illnesses such as cancer (Alper et al., 2003) , infectious diseases, metabolic and cardiovascular disorders, allergies, tuberculosis (Sharma et al., 2011) and different inflammatory conditions. Thus, in order to increase the activity of benzimidazole derivatives its coordination behaviour with transition metals such as Pd(II), Co(II), Ni(II), Cu(II) and Cd(II) (Tellez et al., 2008) has been explored. 
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Refinement
H atoms were included in calculated positions (C-H = 0.93 Å for aromatic H, C-H =0.97 Å for methylene H, and C-H= 0.96 Å for methyl H), and refined using a riding model, with U iso (H) = 1.2U eq of the carrier atoms. The hydroxyl H atoms were located in a difference map and refined with O-H = 0.85±0.01 Å, and with U iso (H) = 1.2U eq (O).
Computing details
Data collection: SMART (Bruker, 2007 ); cell refinement: SAINT (Bruker, 2007) ; data reduction: SAINT (Bruker, 2007 );
program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXTL (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
SHELXTL (Sheldrick, 2008) .
Figure 1
The molecular structure of the title compound, showing 50% probability displacement ellipsoids and the atom numbering scheme.
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